Bausch Health Companies Cash Flow Statement
NYSE: BHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch Health Companies free cash flow
In fiscal 2025, Bausch Health Companies generated $1.40 billion of operating cash flow and spent $397.0 million on capital expenditures. That left free cash flow of $1.00 billion, a free-cash-flow margin of 9.8% of revenue. Free cash flow was down 20.4% from the prior year's $1.26 billion.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch Health Companies cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 120.00M | -72.00M | -611.00M | -212.00M | -937.00M | -559.00M | -1.78B | -4.14B | 2.40B | -2.41B |
| Net Income growth (YoY) | — | — | — | — | — | — | — | -272.38% | — | — |
| Depreciation & Amortization | 1.21B | 1.27B | 1.26B | 1.39B | 1.55B | 1.82B | 2.08B | 2.82B | 2.86B | 2.87B |
| Stock-Based Compensation | 216.00M | 150.00M | 132.00M | 126.00M | 128.00M | 105.00M | 102.00M | 87.00M | 87.00M | 165.00M |
| Change in Working Capital | -219.00M | 7.00M | -582.00M | -396.00M | -128.00M | -366.00M | -318.00M | 18.00M | 844.00M | -110.00M |
| Operating Cash Flow | 1.40B | 1.60B | 1.03B | -728.00M | 1.43B | 1.11B | 1.50B | 1.50B | 2.29B | 2.09B |
| Capital Expenditures | -397.00M | -337.00M | -215.00M | -218.00M | -269.00M | -302.00M | -270.00M | -157.00M | -171.00M | -235.00M |
| Investing Cash Flow | -595.00M | -454.00M | -2.15B | -303.00M | 409.00M | -261.00M | -419.00M | -196.00M | 2.89B | -125.00M |
| Share Repurchases | — | — | — | — | — | — | — | — | 0 | 0 |
| Debt Issued | 10.55B | 661.00M | 3.29B | 6.84B | 2.10B | 3.46B | 5.96B | 8.94B | 9.42B | 1.22B |
| Debt Repaid | -11.19B | -1.46B | -1.71B | -7.85B | -3.44B | -5.64B | -4.41B | -10.10B | -14.20B | -2.44B |
| Financing Cash Flow | -742.00M | -868.00M | 1.48B | -474.00M | -1.51B | -2.29B | 1.44B | -1.35B | -4.96B | -1.96B |
| Net Change in Cash | 124.00M | 239.00M | 371.00M | -1.53B | 303.00M | -1.43B | 2.52B | -74.00M | 255.00M | -55.00M |
| Free Cash Flow | 1.00B | 1.26B | 817.00M | -946.00M | 1.16B | 809.00M | 1.23B | 1.34B | 2.12B | 1.85B |
This table shows 10 annual periods of Bausch Health Companies's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BHC's reporting calendar. What is a cash flow statement?